07/10/2025
3:17 PM | Elite Pharmaceuticals (Issuer)
Plassche Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
3:15 PM | Elite Pharmaceuticals (Issuer)
Plassche Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2025
9:58 AM | Elite Pharmaceuticals (Subject)
Plassche Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2025
3:05 PM | Elite Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
06/23/2025
6:05 AM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
6:05 AM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
3:40 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
6:10 AM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
3:20 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
3:35 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:51 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
4:23 PM | Elite Pharmaceuticals (Issuer)
Plassche Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
7:27 AM | Elite Pharmaceuticals (Subject)
Plassche Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
3:47 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:30 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
4:16 PM | Elite Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free ELTP Stock Alerts